Plasma glucose, insulin and cardiovascular responses after intravenous intracerebroventricular injections of insulin, 2-deoxyglucose and glucose in rats. 1994

S Schultz-Klarr, and J Wright-Richey, and J C Dunbar
Department of Physiology, Wayne State University, School of Medicine, Detroit, MI 48201.

To determine the possibility that insulin and/or glucose may directly or indirectly modulate cardiovascular tone, we measured plasma glucose, arterial pressure and heart rate after the injection of insulin, 2-deoxyglucose (2-DG) and glucose into the femoral vein or into the lateral ventricles of Wistar rats. The systemic administration of insulin significantly decreased plasma glucose, while its intracerebroventricular (ICV) infusion had little effect on plasma glucose, although it resulted in a significant increase in plasma insulin. Both the peripheral and the ICV administration of insulin significantly decreased mean arterial pressure (MAP) and ICV insulin decreased heart rate. Injections of 2-deoxyglucose were used to help differentiate the effects of insulin from those of insulin-induced glucopenia. When infused systemically, 2-DG increased plasma glucose while ICV 2-DG had no significant effect on plasma glucose levels. When 2-DG was administered systemically, MAP and heart rate were increased slightly; however, they were significantly decreased when 2-DG was administered centrally. Both ICV and systemic administration of glucose increased plasma insulin even though ICV glucose did not significantly change the plasma glucose level. Both systemic and ICV administration of glucose significantly decreased MAP and heart rate. These results suggest that increasing the insulin and/or glucose concentration of the CNS environment may have a direct influence on autonomic outflow resulting in decreased MAP and heart rate. Central glucopenia induced by 2-DG suppressed sympathetic or increased parasympathetic outflow, while systemic glucopenia stimulated cardiovascular tone. Both systemic and central glucose administration suppressed the cardiovascular tone to a lesser extent than did administration of insulin.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007276 Injections, Intraventricular Injections into the cerebral ventricles. Intraventricular Injections,Injection, Intraventricular,Intraventricular Injection
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002319 Cardiovascular System The HEART and the BLOOD VESSELS by which BLOOD is pumped and circulated through the body. Circulatory System,Cardiovascular Systems,Circulatory Systems
D002320 Cardiovascular Physiological Phenomena Processes and properties of the CARDIOVASCULAR SYSTEM as a whole or of any of its parts. Cardiovascular Physiologic Processes,Cardiovascular Physiological Processes,Cardiovascular Physiology,Cardiovascular Physiological Concepts,Cardiovascular Physiological Phenomenon,Cardiovascular Physiological Process,Physiology, Cardiovascular,Cardiovascular Physiological Concept,Cardiovascular Physiological Phenomenas,Concept, Cardiovascular Physiological,Concepts, Cardiovascular Physiological,Phenomena, Cardiovascular Physiological,Phenomenon, Cardiovascular Physiological,Physiologic Processes, Cardiovascular,Physiological Concept, Cardiovascular,Physiological Concepts, Cardiovascular,Physiological Phenomena, Cardiovascular,Physiological Phenomenon, Cardiovascular,Physiological Process, Cardiovascular,Physiological Processes, Cardiovascular,Process, Cardiovascular Physiological,Processes, Cardiovascular Physiologic,Processes, Cardiovascular Physiological
D003847 Deoxyglucose 2-Deoxy-D-arabino-hexose. An antimetabolite of glucose with antiviral activity. 2-Deoxy-D-glucose,2-Deoxyglucose,2-Desoxy-D-glucose,2 Deoxy D glucose,2 Deoxyglucose,2 Desoxy D glucose
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose

Related Publications

S Schultz-Klarr, and J Wright-Richey, and J C Dunbar
January 1983, Prostaglandins,
S Schultz-Klarr, and J Wright-Richey, and J C Dunbar
May 1985, Naunyn-Schmiedeberg's archives of pharmacology,
S Schultz-Klarr, and J Wright-Richey, and J C Dunbar
October 2020, Drug metabolism and disposition: the biological fate of chemicals,
S Schultz-Klarr, and J Wright-Richey, and J C Dunbar
November 1983, Research communications in chemical pathology and pharmacology,
S Schultz-Klarr, and J Wright-Richey, and J C Dunbar
December 1988, Journal of applied physiology (Bethesda, Md. : 1985),
S Schultz-Klarr, and J Wright-Richey, and J C Dunbar
January 1985, Acta medica Scandinavica,
S Schultz-Klarr, and J Wright-Richey, and J C Dunbar
November 1983, Canadian journal of physiology and pharmacology,
S Schultz-Klarr, and J Wright-Richey, and J C Dunbar
February 1983, Pharmacological research communications,
S Schultz-Klarr, and J Wright-Richey, and J C Dunbar
March 1978, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
S Schultz-Klarr, and J Wright-Richey, and J C Dunbar
May 1980, The American journal of physiology,
Copied contents to your clipboard!